Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB26FATYM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,047
Award facts
- Contract value 100% obligated
- $15,047.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,047.26 to DMS Pharmaceutical Group Inc. for Enbrel 50 mg/mL SureClick medication on October 23, 2025, with completion expected by October 24, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected through a firm fixed-price contract without set-aside designation. The delivery will be fulfilled at the company's facility in Conshohocken, Pennsylvania. This award represents a continuation of DMS Pharmaceutical Group's substantial pharmaceutical supply activity supporting the Department of Defense medical supply chain.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply pharmaceuticals and medical consumables to military healthcare facilities worldwide. The underlying IDC, valued at $499.999 billion with a completion date of December 31, 2036, establishes DMS Pharmaceutical Group as a regional prime vendor contractor capable of delivering diverse pharmaceutical products including branded and generic medications, biologics, and medical consumables. The company's established performance across numerous delivery orders demonstrates its capacity to meet the specialized pharmaceutical requirements of the Department of Defense's global healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FATYM?
SPE2DB26FATYM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FATYM worth?
The government has obligated $15,047 on SPE2DB26FATYM.
Is contract SPE2DB26FATYM an order under another contract?
Yes. SPE2DB26FATYM is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB26FATYM competed?
The extent of competition for SPE2DB26FATYM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award